2-(4-Chloro-3-(dibutylcarbamoyl)-5-methyl-1H-pyrazol-1-yl)-5-(naphthalen-2-ylsulfonylcarbamoyl)benzoic acid → HCID 71062203, compound

HRID 528948Notes

Reaction equation

HRID 528948 reaction equation
ClC1C(C(=O)N(CCCC)CCCC)=NN(C2C=CC(C(=O)NS(C3C=CC4C(=CC=CC=4)C=3)(=O)=O)=CC=2C(O)=O)C=1C.[Cl:44][C:45]1[C:46]([C:86](=[O:96])[N:87]([CH2:92][CH2:93][CH2:94][CH3:95])[CH2:88][CH2:89][CH2:90][CH3:91])=[N:47][N:48]([C:51]2[CH:61]=[CH:60][C:59]([C:62](=[O:85])[NH:63][S:64]([C:67]3[CH:68]=[C:69]4[C:73](=[CH:74][CH:75]=3)[N:72]([CH2:76][C:77]3[CH:82]=[CH:81][C:80]([Cl:83])=[C:79]([Cl:84])[CH:78]=3)[CH2:71][CH2:70]4)(=[O:66])=[O:65])=[CH:58][C:52]=2[C:53]([O:55]CC)=[O:54])[C:49]=1[CH3:50]>>[Cl:44][C:45]1[C:46]([C:86](=[O:96])[N:87]([CH2:92][CH2:93][CH2:94][CH3:95])[CH2:88][CH2:89][CH2:90][CH3:91])=[N:47][N:48]([C:51]2[CH:61]=[CH:60][C:59]([C:62](=[O:85])[NH:63][S:64]([C:67]3[CH:68]=[C:69]4[C:73](=[CH:74][CH:75]=3)[N:72]([CH2:76][C:77]3[CH:82]=[CH:81][C:80]([Cl:83])=[C:79]([Cl:84])[CH:78]=3)[CH2:71][CH2:70]4)(=[O:65])=[O:66])=[CH:58][C:52]=2[C:53]([OH:55])=[O:54])[C:49]=1[CH3:50]

Participants

3

Procedure

Following a procedure analogous to that for the synthesis of Intermediate 91F, ethyl 2-(4-chloro-3-(dibutylcarbamoyl)-5-methyl-1H-pyrazol-1-yl)-5-(1-(3,4-dichlorobenzyl)indolin-5-ylsulfonylcarbamoyl)benzoate (355 mg, 0.44 mmol) was converted to the title compound (290 mg, 85%). 1H NMR (DMSO-d6) δ 8.14 (d, J=2.0 Hz, 1H), 8.17 (dd, J=8.3, 2.1 Hz, 1H), 7.69-7.57 (m, 5H), 7.32-7.30 (m, 1H), 6.65 (d, J=8.6 Hz, 1H), 4.45 (s, 2H), 3.53 (t, J=8.7 Hz, 2H), 3.40-3.28 (m, 4H), 3.05 (t, J=8.4 Hz, 2H), 2.11 (s, 3H), 1.56-1.41 (m, 4H), 1.33-1.27 (m, 2H), 1.15-1.08 (m, 2H), 0.91 (t, J=7.3 Hz, 3H), 0.74 (t, J=7.4 Hz, 3H); MS(ESI+) m/z 776.2 (M+H)+.

Sources & evidence

ORD record
ord-3666a38905a0484dbc57cdd25c31f977
Source dataset
uspto-grants-2016_05
Patent number
US09346795B2

Reaction notes

Loading…